Cambrex (CBM) Inventory Turnover Ratio, from third quarter 2019 to third quarter 2018, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Cambrex Corp  (CBM)
 

Cambrex Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cambrex Corp inventory turnover ratio, the Cambrex Corp's ability to sell and replace its inventory in the third quarter 2019, sequentially increased to 3.54 in the third quarter 2019, a new company high. Average inventory processing period, for the Cambrex in Sep 30 2019 quarter, has decreased to 103 days, compare to 108 days, in the Jun 30 2019 quarter.

Within Healthcare sector 162 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2019, to 1393, from total ranking in the second quarter 2019 at 1441.

CBM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cambrex Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CBM Inventory Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Inventory Growth 10.68 % 10.07 % 14.33 % -19.84 % -37.15 %
Y / Y Cost of Sales Growth 35.84 % 30.68 % 15.88 % -16.82 % 9.38 %
Inventory Turnover Ratio (TTM) 3.54 3.39 3.22 3.2 3.16
CBM's Total Ranking # 1393 # 1441 # 1440 # 1501 # 1440
Average inventory processing period 103 108 113 114 115
Seq. Inventory Growth 4.68 % -8.32 % 7.62 % 7.15 % 4.1 %
Seq. Cost of Sales Growth -14.35 % 9.04 % 21.57 % 19.64 % -17.6 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 51
Healthcare Sector # 163
Overall Market # 1393

Inventory Turnover Ratio Statistics
High Average Low
3.54 2.47 1.99
(Sep 30 2019)   (Dec 31 2017)



CBM Company Profile >> Back to CBM Efficiency Comparisons >> Compare CBM Inventory Turnover Ratio to its Competitors

Financial Statements
Cambrex's Inventories $ 115 Millions Visit CBM's Balance sheet
Cambrex's Cost of Revenues TTM $ 402 Millions Visit CBM's Income Statement
What are CBM's Sales? Visit CBM's Sales by Segment

Other Inventory Turnover Ratios
Cambrex's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CBM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CBM's Competitors
Inventory Turnover Ratio for CBM's Suppliers
Inventory Turnover Ratio for CBM's Customers

You may also want to know
CBM's Sales Growth Rates CBM's Pe Price to earnings ratio CBM's Receivables Turnover Ratio CBM's Stock Quote
CBM's Net Income Growth Rates CBM's Ps Price to Sales ratio CBM's Sales per Employee CBM's Asset Turnover Ratio
CBM's Net Margin CBM's Pb Price to Book ratio CBM's Financial Strength Ratios CBM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2019 Inventories at quarter ending Sep 30 2019
Charles River Laboratories International inc   9.64 $ 1,320.304  Millions$ 137  Millions
Steris Plc  9.46 $ 1,651.871  Millions$ 175  Millions
Tenet Healthcare Corp  9.27 $ 2,857.000  Millions$ 308  Millions
Nuo Therapeutics Inc   9.14 $ 0.128  Millions$ 0  Millions
Align Technology inc   8.48 $ 635.994  Millions$ 75  Millions
Perspective Therapeutics Inc   8.37 $ 4.308  Millions$ 1  Millions
Mallinckrodt Plc  8.36 $ 2,727.500  Millions$ 326  Millions
Twist Bioscience Corporation  8.31 $ 47.426  Millions$ 6  Millions
Enzo Biochem Inc  7.63 $ 58.204  Millions$ 8  Millions
Innovage Holding Corp   7.62 $ 15.418  Millions$ 2  Millions
Kewaunee Scientific Corporation  7.56 $ 122.844  Millions$ 16  Millions
Ufp Technologies Inc   7.55 $ 145.923  Millions$ 19  Millions
Portola Pharmaceuticals inc   7.54 $ 27.226  Millions$ 4  Millions
Musclepharm Corporation  7.48 $ 73.130  Millions$ 10  Millions
Veracyte Inc   7.44 $ 35.108  Millions$ 5  Millions
Vericel Corporation  7.41 $ 35.615  Millions$ 5  Millions
Dexcom Inc   7.40 $ 758.700  Millions$ 103  Millions
Biotricity Inc   7.36 $ 0.410  Millions$ 0  Millions
Catalent Inc   7.26 $ 1,796.600  Millions$ 248  Millions
Htg Molecular Diagnostics Inc  7.24 $ 8.756  Millions$ 1  Millions
National Vision Holdings Inc   7.11 $ 792.447  Millions$ 111  Millions
Omnova Solutions Inc  7.06 $ 582.800  Millions$ 83  Millions
Avalo Therapeutics Inc   7.06 $ 5.605  Millions$ 1  Millions
Avid Bioservices Inc   6.99 $ 54.259  Millions$ 8  Millions
Horizon Therapeutics Public Limited Company  6.91 $ 365.853  Millions$ 53  Millions
Caredx Inc   6.90 $ 36.868  Millions$ 5  Millions
Carlisle Companies Incorporated  6.85 $ 3,402.800  Millions$ 497  Millions
Fonar Corporation  6.82 $ 12.039  Millions$ 2  Millions
Global Cord Blood Corp  6.79 $ 34.479  Millions$ 5  Millions
Wearable Health Solutions, Inc.  6.65 $ 0.402  Millions$ 0  Millions

Date modified: 2026-08-29T14:49:27+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.